State Street Corp Boosts Holdings in Doximity, Inc. (NASDAQ:DOCS)

State Street Corp lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,693,982 shares of the company’s stock after acquiring an additional 88,922 shares during the quarter. State Street Corp owned 1.99% of Doximity worth $160,947,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of DOCS. Farther Finance Advisors LLC raised its position in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares during the last quarter. Quarry LP increased its position in shares of Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares in the last quarter. Morse Asset Management Inc purchased a new stake in shares of Doximity in the 3rd quarter valued at about $46,000. Finally, First Horizon Advisors Inc. boosted its position in shares of Doximity by 80.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock valued at $48,000 after purchasing an additional 760 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on DOCS. Canaccord Genuity Group reiterated a “hold” rating and issued a $60.00 price objective (up previously from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $19.00 to $41.00 in a research report on Friday, November 8th. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, Truist Financial increased their target price on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Twelve investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $52.44.

Doximity Trading Down 1.1 %

Shares of DOCS stock opened at $52.14 on Friday. The company has a market cap of $9.73 billion, a price-to-earnings ratio of 59.93, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. The stock has a 50 day simple moving average of $48.05 and a 200-day simple moving average of $37.88. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.